chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Severe joint pain in knuckles of left hand and minor joint pain in left elbow.  Loss of strength and manual dexterity in hand due to pain.  Pain began within week of shot and is starting to subside 2.5 months later.
fluid retention in my fingers (both hands).; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 64 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 15Mar2021 09:30 (Lot number: EN6205) at the age of 64 years as dose 1, single for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. The following information was reported: FLUID RETENTION (non-serious) with onset 22Mar2021, outcome "not recovered", described as "fluid retention in my fingers (both hands).". Therapeutic measures were not taken as a result of fluid retention.  Additional information: It was reported that he was experiencing fluid retention in his fingers (both hands). His thumbs seem OK. Fluid retention first occurred about 1 week after dose one but he did not associate it with the vaccine since he was expecting an immediate reaction (which he did not have), local pain at injection site (which he did not have) nor did he have other reported general symptoms.   No follow-up attempts are possible. No further information is expected.
Child became limp, eyes rolled back into his head. He was listless. Had a low fever (100 degrees). This lasted about 2 hours. We was back to his normal self by afternoon time.
scarring on her abdomen; shingles; Information has been received from a lawyer concerning a case in litigation and refers to a female patient of an unknown age. No information regarding the patient's medical history, concurrent conditions and concomitant medications was provided. In or around March 2017, the patient was inoculated with zoster vaccine live (ZOSTAVAX) (dose, route of administration, vaccination site, lot # and expiry date were not specified) for routine health maintenance and for its intended purpose: the prevention of shingles. In or around January 2018, the patient was diagnosed by a physician with shingles. As a result of the shingles diagnosis, she now had a scarring on her abdomen. As a direct and proximate result of the Company's defective zoster vaccine live (ZOSTAVAX) vaccine, the patient's symptoms have resulted in physical limitations not present prior to using the Company's product. The patient also experienced mental and emotional distress due to resulting physical limitations and seriousness of the patient's condition. As a result of the manufacture, marketing, advertising, promotion, distribution and/or sale of zoster vaccine live (ZOSTAVAX), the patient sustained severe and permanent personal injuries. Further, as a tragic consequence of the Company's wrongful conduct, the patient suffered serious, progressive, permanent, and incurable injuries, as well as significant conscious pain and suffering, mental anguish, emotional distress, loss of enjoyment of life, physical impairment and injury. As a direct and proximate result of the Company's conduct, the patient has incurred and would continue to incur medical expenses and other economic harm as a direct result of zoster vaccine live (ZOSTAVAX). The outcome of the events was reported as not recovered ("also reported as was diagnosed with shingles that lasted for several weeks"). The causality was related.  The event of shingles and scarring on abdomen were considered to be disabling.
Broke out in rash after receiving the second dose. It is going away and no further issues. Did not have reaction to 1st dose
Patient's arm was red around the area where the injection was given (similar to a bulls-eye rash). Patient stated it does not hurt. Patient stated it did start out as a bruise and progressed to the red rash. Discussed with patient to follow up with MD.
Within 2 hours of the shot I started with chills, arm started to ache and by midnight my whole body ached.  I continued with all those  symptoms and have a fever over 100 most of Sunday along with feeling sick to my stomach and head hurt.  Today is Monday March 1 and I feel weak at 10:15 AM but otherwise doing better than the last two days at the moment.
feel very ill!; This case was reported by a consumer via interactive digital media and described the occurrence of illness in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced illness. On an unknown date, the outcome of the illness was unknown.   It was unknown if the reporter considered the illness to be related to Shingles vaccine.  Additional details were provided as follows: This patient-self reported this case. The age at vaccination was not reported. The patient received the shingles shot that made him/ her feel very ill. The patient stated that it was better than getting shingles. This case was linked with US2021AMR196890, reporter by the same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR196890:same reporter (reporter case)
Information has been received from the registered nurse on 02-JAN-2014. It was reported that GARDASIL were stored in improper temperatures and were administered to overall number of 132 patients. This report refers to one of the patient's involved: a patient of unspecified age and gender, who had administered dose of GARDASIL on 06-MAY-2013 (lot # H011350, Expiration Date: 21-FEB-2015). This is one of the report from the same source, linked reports. Additional information is not expected.
Hepatosplenomegaly. Patient new to me in hematology clinic, referred to rule out bleeding disorder due to irregular periods, and had palpated splenomegaly that was then confirmed by imaging and has persisted. This finding was not previously on other imaging and was an incidental finding on physical exam confirmed by ultrasound and MRI.
Patient reported mild swelling and itchiness in his hands and feet starting approximately two days after vaccination.  He was advised to take diphenhydramine as directed per over-the-counter packaging.  He was instructed to contact his primary care physician/urgent care if the condition were to worsen or if he were to have any difficulty breathing.
pt recv vax 1FEB96 & had chills in lt arm that evening;next day pt devel itchy spots on front of shins, & aching on back of knees & elbows;rash devel on legs & thigh w/itching;dx allergic react poss secondary to hep B vax;
6 cm bright red area w/ 10x11 induration at injection site. HA, body aches, anorexia, lassitude, swelling & fatigue lasting 5-7d.
Vaccine administered after more than 1 temperature excursion; Vaccine administered after more than 1 temperature excursion; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after more than 1 temperature excursion) and POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after more than 1 temperature excursion) in a 62-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Apr-2021 at 10:04 AM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 03-Apr-2021, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after more than 1 temperature excursion). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after more than 1 temperature excursion). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after more than 1 temperature excursion) and POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after more than 1 temperature excursion) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The age of patient was provided as 62.67.  Concomitant products were not provided.  On 03-Apr-2021, Excursion time was 9 AM, temperature was 34, total doses given for the day was 210, condition of vaccine prior to administration was not frozen, vaccine was moved to fridge on 30-Mar-2021, vial was moved to clinic on 03-Apr-2021. 20 vials were sent to clinic. Vaccine BUD date was 29-Apr-2021.  On 03-Apr-2021, vials were stored in cooler 1, at following time and temperature respectively, 8 AM: 38, 9 AM: 34, 10 AM: 38, 11 AM: 42, 12 AM: 41, 1PM: 41, 2 PM: 41, 3 PM: 40, 4 PM: 40 and 5 PM: 41.  The vials were only punctured right before administration and all doses were drawn from the vial due to high-pace clinic.  Temperature recordings were taken using a Fisher brand traceable temperature monitor at every hour.  After administration, the vial was returned to the freezer/refrigerator, or maintained at room temperature.  It was reported that the patient was administered with vaccines that experienced more than 1 temperature excursion during 33 weeks in 2021. The HCP explained that each time a vial was put into a cooler, there was a period of 1 hour or 1 and half hour approximately, when the temperature data logger registered 34 or 35 degree F.  Treatment medications were not reported.
sx appeared 24hrs p/vax swelling of rt thigh; no fever noted per mom called MD said was nl; did warm compresses @ APAP; swelling cont; to ER 12NOV95 said leg was abscessed; MD stated no need to do I&D; has not been able to move leg nl;
Noticed next day (Saturday) swelling size of peach near muscle - warm to touch Urgent Care->Prednisone, BENADRYL, Hydrocortisone.
Sick; SWEATING WITH HEADACHES; FATIGUED; VACCINE CAUSED SORE ARM; SWEATING WITH HEADACHES; FLU-LIKE SYMPTOMS with HUMIRA (ADALIMUMAB); This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (Sick), HYPERHIDROSIS (SWEATING WITH HEADACHES), FATIGUE (FATIGUED), VACCINATION SITE PAIN (VACCINE CAUSED SORE ARM) and HEADACHE (SWEATING WITH HEADACHES) in an adult male patient who received mRNA-1273 (Spikevax) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) solution for injection for Plaque psoriasis.    Concurrent medical conditions included Plaque psoriasis.   On an unknown date, the patient received dose of mRNA-1273 (Spikevax) (Intramuscular) 1 dosage form and ADALIMUMAB (HUMIRA) (Subcutaneous) at an unspecified dose. On an unknown date, the patient experienced ILLNESS (Sick), HYPERHIDROSIS (SWEATING WITH HEADACHES), FATIGUE (FATIGUED), VACCINATION SITE PAIN (VACCINE CAUSED SORE ARM), HEADACHE (SWEATING WITH HEADACHES) and INFLUENZA LIKE ILLNESS (FLU-LIKE SYMPTOMS with HUMIRA (ADALIMUMAB)). At the time of the report, ILLNESS (Sick), HYPERHIDROSIS (SWEATING WITH HEADACHES), FATIGUE (FATIGUED), VACCINATION SITE PAIN (VACCINE CAUSED SORE ARM) and HEADACHE (SWEATING WITH HEADACHES) had resolved and INFLUENZA LIKE ILLNESS (FLU-LIKE SYMPTOMS with HUMIRA (ADALIMUMAB)) had not resolved.        The action taken with mRNA-1273 (Spikevax) (Intramuscular) was unknown.       No concomitant medications was reported.  It was unknown if patient was enrolled in a COVID-19 Vaccine Trial.  The reporter's causality for the event's of SICK, FATIGUED, SWEATING WITH HEADACHES unknown onset, VACCINE CAUSED SORE ARM, SWEATING WITH HEADACHES unknown onset and FLU-LIKE SYMPTOMS was not provided for Humira.  No treatment drug details was reported.
Information has been received from a physician concerning a female who in approximately May 2007, was vaccinated with the third dose of Gardasil and had a reaction at the injection site and pain on her arm right after receiving the injection. As of 08-JUN- 2007, the patient's experiences had improved. Additional information has been requested. 10/08/07 This is in follow-up to report(s) previously submitted on 7/6/2007. Information has been received from a physician concerning a 19 year old female who on 02-MAY-2007 was vaccinated with the third dose of GARDASIL, IM in the right arm. Concomitant medication was not reported. It was reported that there was no reaction with the first and second doses of GARDASIL. No illness was reported at the time of vaccination. In approximately May 2007, the patient experienced pain on her right arm. On 04-MAY-2007 the second day after she received the vaccine, the patient developed a 30 mm local reaction erythema, numbness and warm to touch. Subsequently 36 hours later, the patient recovered from the 30 mm local reaction erythema, numbness and warm to touch. Additional information is not expected.
Started to feel tingling under the arm that had the vaccine. Then he noticed rash. Has hive-type rash on inside/underside of his left arm and along left chest wall initially. A couple of hours later developed a couple of spots on anterior part of arm/antecubital fossa.
Patient had an adverse reaction to 3rd dose of the Pfizer vaccine. Per chart: Immediately after receiving vaccination, she noted heavy breathing. She needed to lie down and elevate her feet. She proceeded to get out of chair and lie herself on the ground in effort to elevate feet. She declined to go to ER for evaluation. She admitted to vasal vagal response every time she gets injections or blood drawn.
June 28, 2022 - after likely COVID exposure, felt ill and tested positive with a home rapid covid test.  Received Paxlovid 6/28/22, completed paxlovid 7/2/22. Highest fever of 100.7F was managed with tylenol until resulted in temperatures of 98.3-96.8F, Temperature was normal by 7/2/22 without tylenol.
Had large swelling, tenderness sand pain around injection for 3 weeks. Received Benadryl and Tylenol but did not seem to help. The swelling was between my shoulder and elbow, the width of my arm. I have no need for further shots, however the military insists I continue getting them.  Follow up on 06/05/2000: "Patient recovered from adverse event."
sore arm with my first dose; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm with my first dose) in a 74-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030H21B) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Jan-2022, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (sore arm with my first dose). At the time of the report, PAIN IN EXTREMITY (sore arm with my first dose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment medication was reported. No concomitant medication was reported.   This case was linked to MOD-2022-473668 (Patient Link).
Patient is fully vaccinated. Admitted on 2/8/2022 with COVID concerns.  COVID + on 2/11/2022. 66-year-old male with a history of severe MR, deaf, blind presenting from group home with weakness and cough.  EKG: normal sinus rhythm, with RBBB, no signs of ischemia and no infarction. Chest x-ray negative for acute process.  BP low but improved with IV fluids. Rocephin also given. Discharged to group home.
At bedtime, felt chills. Overnight developed muscle aches and a headache. On 3/12 9:45am still feeling headache and body aches.
3 hours after shot I hit metallic taste in my mouth, I then became so severely tired and light headed.  Got chills. Hot & cold nauseated .  It?s three days later I?m still very tired. Headaches , throats feels swollen , glands swollen.  I feel like I got the flu! When is this going to end ?
Pt received vaccines on 23AUG2022; Pt reported back to the clinic 25AUG2022 with a swollen lymph node, red L thigh, and a fever.  Pt was prescribed Ibuprofen and Augmentin.  Pt was asked to return to clinic 26AUG2022 to see if the issue resolved itself.
fever of 101.5; This case was reported by a consumer and described the occurrence of fever in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced fever. The patient was treated with paracetamol (Tylenol). On an unknown date, the outcome of the fever was unknown.   It was unknown if the reporter considered the fever to be related to Shingrix.  Additional details were reported as follows: The age at vaccination was not reported. The reporter stated that his wife running a fever of 101.5 after taking the shingles vaccine.  She had taken two Tylenol for the fever. The reporter asked was there anything else she should do.
Moderna Covid-10 Vaccine        Initial vaccination dose  vaccination March 23.  Felt fine till March 26.  March 26 symptoms; Lower abdominal discomfort, low grade fever (99-99.9), lethargic.  Late day March 28 symptoms; moderate lower abdominal pain, 100.9 fever, intermittent chills, very lethargic, body aches, fuzzy headed and tired.  March 29 symptoms; low grade fever, body aches, fuzzy headed and tired.   March 30 symptoms (today)  none  Treatment:  Beginning March 28 and ending March 30- bed rest and plenty of fluids.  No other treatment used.
23 days after receiving the vaccine was hospitalized because of an urosepsis; A spontaneous report was received from a other healthcare professional concerning a 70-year-old male patient experienced urosepsis 23 days after receiving the vaccine.  The patient's medical history was not provided. No relevant concomitant medications were reported.  The patient received the first of the two planned doses of mRNA-1273 on 01-FEB-2021 in unknown arm (Batch: 004M20A)  intramuscularly for prophylaxis of COVID-19 infection.   On 03-MAR-2021, 23 days after receiving the vaccine was hospitalized because of an urosepsis.  No treatment information was provided.  Action taken with mRNA-1273 in response to the event was unknown.  The outcome of the event was unknown.  The assessment was not provided for the event.; Reporter's Comments: The event was consistent with increased risk of complications associated with elderly age of patient. Company assessed the event to be unlikely related to company product.
This spontaneous report was received from a nurse referring to unspecified patients of unknown age and gender. Information about concurrent condition, concomitant medication and medical history was not provided. On unknown dates, the patients were inadvertently administered with GARDASIL 9 (lot # M044717, expiration date 19-JUL-2019, 0.5 ml, intramuscular) that had been improperly stored (incorrect product storage) for prophylaxis. The temperature was 1 centigrade degree (°C), and the time frame was 2 hours 23 minutes. There was no previous temperature excursion. Data logger was involved. No adverse effects reported. This is one of several reports received from the same reporter.; Sender's Comments: US-009507513-1708USA007035: US-009507513-1708USA007034:
Warm- reddened 5" x 5" redness and swollen at (R) upper thigh IM. Cephalexin 250/5cc 7 ml tid x 10days.
patient was administered Moderna COVID vaccine approx 415pm and about 5-7 minutes after she reported being lightheaded. Also reported neck pain, chest/throat tightness, slightly itchy throat, clogged ears, and a cold feeling. I took her BP and it was elevated at 156/94. I monitored patient over the next 30-35 minutes and she asked for water and crackers. She was not having any difficulty breathing, did not complain of throat closing so epi pen was NOT administered. She slowly improved over those 30-35 minutes. She declined me calling 911. She left with her boyfriend approx 45 minutes after onset of symptoms. I called her at approx 7pm the same night and she reported feeling "fine".
19 hours after injection, experienced; soreness at injection site, muscle fatigue, and exhaustion.
Noted the onset of localized redness and swelling around her injection site for the first two days following her vaccination.  This was followed by the presence of multiple small "bumps" that contained clear fluid.  She sought medical attention on the 16th and was told this was a large reaction to AVA.  The redness and swelling did not extend below her elbow.  She was given MOTRIN and it was beginning to clear the following day.  Then approx 9 days after her vaccination she began to notice intense itching all over her body especially on her arms, back and chest with small red bumps on her inner arms and breast. She stated that she never had anything like this before and denied any new soaps, creams, detergents or medication.  She began taking an antihistamine that she had at home that helped a little but the intense itching returned just before the medication wore off.  She went to the clinic again and was told that it was a heat rash and was given some hydrocortisone cream.  Symptoms: Pruritus, diffuse, Erythema, Edema at injection site 30-55mm, Lesions, Vesicle.
Fever 101.3  night of 8/4 to present Body aches.   night of 8/4 to present sense of weakness same time period * All tolerable at this time
Initial and follow-up information has been received from a physician concerning a 28 year old female who was vaccinated with the first dose of GARDASIL vaccine, on 07-MAY-2007. Two days after receiving the first injection, she experienced swelling in her lymph nodes (under her arm and in her neck). She sought unspecified medical attention. There were no diagnostic or laboratory tests performed. Subsequently the patient recovered. On an unspecified date, the patient was vaccinated with the second dose of GARDASIL vaccine. She did not have any adverse reactions to the second dose. Additional information has been requested. This is in follow-up to report (s) previously submitted on 7/16/2007. Additional information is not expected.
After about 15-20 mins, patient started to experiencing symptoms of mild to moderate itching over several different areas of skin.  Patient acknowledged symptoms but felt that he was alright.  Symptoms increased to moderate continuous itching most promiment on hands, forearms, lateral sides of neck. Patient had c/o of headache, slight dizziness, increased HR (sustained 110s) and increased BP (approx 184/130). Pulse ox was 99% on RA.  No trouble breathing, no angioedema noted.   Informed pharmacist and ambulated patient to ER for evaluation.   ER continued observation, administered famotidine 20mg (oral), diphenhydramine 50mg (IM), dexamethasone 10mg (IM).  Patient remained stable and was discharged within an hour with a steroid pack.
This spontaneous report was received from a registered pharmacist refers to a patient of unknown age. On 21-SEP-2012 the patient was vaccinated with a dose of 0.5 ml PNEUMOVAX 23 (lot #: 669579/0595AA) which was expired on 30-AUG-2012. No adverse symptoms reported. Additional information has been requested.
Redness left upper extremity. Large area of erythema and induration upon exam. Orapred 3/4 teaspoon for 3 days, cool compresses, Advil/Tylenol if fever developed.
Starting late in the afternoon on the day of immunization and continuing all the following day, I experienced significant fatigue and body aches, which for me is a typical response to a vaccine.  The second night, I had strong chest pains which were reduced a little by propping myself up in an attempt to sleep.  I contacted my primary care physician the following morning (4/15/2021) and was advised to go to the emergency room.  At Hospital, they performed lab tests and imaging tests noted below.  I then had a follow-up appointment with my primary care physician, Dr. on 4/20/2021 who ordered follow-up lab work.